CANbridge Pharmaceuticals Company

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
Technology: Other
Industry: Biotechnology, Health Care, Pharmaceutical
Headquarters: China
Founded Date: 1-1
Employees Number: 101-250
Funding Status: Late Stage Venture
Estimated Revenue: $1M to $10M
Last Funding Date: 43879
Last Funding Type: Series D

Visit Website
info@canbridgepharma.com
Register and Claim Ownership